Please assess the completion status of the following clinical trial:

Trial Title: Intrathecal Levobupivacaine With Opioids for Caesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women~* above 18 years of age~* gestational pregnancy age ≥ 36 weeks~* height ≥ 155 cm~* weight ≤110 kg~* fetal weight ≥ 2500 g)~* American Society of Anesthesiologists (ASA) Physical Status of I to II~* elective caesarean section surgeries were enrolled.~Exclusion Criteria:~* Local anesthetic allergy~* history of hypersensitivity and anaphylactic reactions~* emergency surgery~* preeclampsia

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): Control Group, Group C: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ Serum saline
- Group Fentanyl (Type: ACTIVE_COMPARATOR): Group Fentanyl, Group F: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml+fentanyl (10 µg)
- Group sufentanil (Type: ACTIVE_COMPARATOR): Group sufentanil, Group S: spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ sufentanil (2.5 µg)

Based on this trial design, predict the completion outcome and termination type (if applicable).